LUCD News and Press, Lucid Diagnostics Inc.

PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities PR Newswire Series D Preferred Stock offering yielded $30 million of gross proceeds and includes warrants exercisable for up to an additional $30 milli...

2026-01-26 10:10:05 ET ... Read the full article on Seeking Alpha For further details see: Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral

2026-01-21 08:47:16 ET More on Lucid Diagnostics, PAVmed PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript Lucid Diagnostics Inc. 2025 Q3 - Results - Earnings Call Presentation PAVmed Inc. 2025 Q3 - Results - Earnings Call Presentation P...

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® PR Newswire NEW YORK , Jan. 21, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagn...

PAVmed Announces Reverse Stock Split PR Newswire NEW YORK , Dec. 30, 2025 /PRNewswire/ --  PAVmed Inc.  (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital...

2025-12-10 10:15:04 ET Ascendiant analyst issues BUY recommendation for LUCD on December 10, 2025 03:12PM ET. The previous analyst recommendation was Buy. LUCD was trading at $1.125 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection PR Newswire Report includes nearly 12,000 patients who underwent Lucid's EsoGuard ® Esophageal DNA Test on samples collected using its EsoCheck ® ...

2025-12-08 05:21:52 ET More on Lucid Diagnostics Lucid Diagnostics Inc. 2025 Q3 - Results - Earnings Call Presentation Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript Lucid Diagnostics: Holding Onto Medicare Coverage Hopes Lucid Diagnostics sig...

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree PR Newswire Recognized as the leading company in its size category in program honoring the top workplaces across the diagnostics and precision-medicine sectors NEW YORK , Nov. 20, 2025 /PRNe...

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum PR Newswire NEW YORK , Nov. 13, 2025 ...